Limited benefit from the addition of immunotherapy to chemotherapy in TKI-refractory EGFR-mutant lung adenocarcinoma.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Lingzhi Hong, Whitney E Lewis, Susan Varghese, Melvin Rivera, Robyn Du, Pingjun Chen, Haley Kemp, Waree Rinsurongkawong, Sadiq Rehmani, Amy R. Spelman, Yasir Y Elamin, Marcelo Vailati Negrao, Boris Sepesi, Don Lynn Gibbons, J. Jack Lee, Jia Wu, Natalie I Vokes, John Heymach, Jianjun Zhang, Xiuning Le
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4281758627